KRONOX173.00

Kronox Lab Sciences Limited

· Chemicals
₹ CrorePeersJAYAGROGNDMCCSRHHYPOLTDCHEMFABPRIMOPLASTIBLENGEMAROMASUDARCOLORMcap ₹642 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth+11.5+1.0
EBITDA Growth+17.0+3.5
EBIT Growth+17.4+1.5
Net Income Growth+18.5+9.3
EPS Growth+18.9+8.7
Total Assets Growth+33.6+29.0
Total Equity Growth+35.9+28.9
Cash from Operations Growth+86.5-26.4
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.